Cendakimab

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	15

98. 好酸球性消化管疾患

臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05175352 (ClinicalTrials.gov)	June 7, 2022	14/12/2021	A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Activ ...	A Phase 1, Open-label, Single-sequence Study to Evaluate Potential Disease-mediated Drug-drug Intera ...	Eosinophilic Esophagitis	Drug: Cendakimab;Drug: CYP substrates	Celgene	NULL	Recruiting	18 Years	75 Years	All	15	Phase 1	United States
2	EUCTR2020-004335-24-ES (EUCTR)	17/05/2022	24/03/2022	A study to evaluate the long-term safety of CC-93538 in adult and adolescent patients who have eosin ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;Switzerland;United Kingdom;Italy;Canada;Argentina;Belgiu ...
3	EUCTR2020-004335-24-PL (EUCTR)	24/03/2022	09/12/2021	A study to evaluate the long-term safety of CC-93538 in adult and adolescent patients who have eosin ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	269	Phase 3	Portugal;United States;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentina;Poland ...
4	EUCTR2020-004335-24-PT (EUCTR)	24/02/2022	03/12/2021	A study to evaluate the long-term safety of CC-93538 in adult and adolescent patients who have eosin ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
5	EUCTR2020-004335-24-IT (EUCTR)	08/02/2022	29/10/2021	A study to evaluate the long-term safety of CC-93538 in adult and adolescent patients who have eosin ...	A Phase 3, Multicenter, Multinational, Open-Label Extension Study to evaluate the Long-Term Safety o ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Trade Name: Cendakimab Product Name: Cendakimab Product Code: [CC-93538] INN or Proposed INN: Cendakima ...	CELGENE INTERNATIONAL II SàRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
6	EUCTR2020-004335-24-DE (EUCTR)	14/01/2022	30/07/2021	A study to evaluate the long-term safety of CC-93538 in adult and adolescent patients who have eosin ...	A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY O ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	259	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;Canada;Argentina;Belgiu ...
7	EUCTR2020-004336-16-ES (EUCTR)	12/01/2022	12/01/2022	A study to evaluate the efficacy and safety of CC-93538 in adult and adolescent patients who have eo ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentin ...
8	EUCTR2020-004336-16-DE (EUCTR)	29/09/2021	01/02/2021	A study to evaluate the efficacy and safety of CC-93538 in adult and adolescent patients who have eo ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentin ...
9	EUCTR2020-004336-16-PT (EUCTR)	24/09/2021	01/04/2021	A study to evaluate the efficacy and safety of CC-93538 in adult and adolescent patients who have eo ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;Canada;Argentin ...
10	EUCTR2020-004336-16-AT (EUCTR)	01/08/2021	22/03/2021	A study to evaluate the efficacy and safety of CC-93538 in adult and adolescent patients who have eo ...	A Phase 3, Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and ...	EOSINOPHILIC ESOPHAGITIS MedDRA version: 20.1;Level: LLT;Classification code 10064220;Term: Eosinoph ...	Product Name: Cendakimab Product Code: CC-93538 INN or Proposed INN: Cendakimab	Celgene International II Sàrl	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	399	Phase 3	Switzerland;Italy;Canada;Argentina;Belgium;Poland;Australia;Germany;Japan;New Zealand;United Kingdom ...

First Previous1 2Next Last